학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 43건 | 목록 1~20
Academic Journal
Nieto-Sanchez A; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Martinez-Lage M; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Puig-Serra P; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Carpintero S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Alonso-Yanez A; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Ojeda-Walczuk P; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Ciemat), Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Ibañez-Navarro M; Pediatric Onco-Hematology Clinical Reseacrh Unit IdiPAZ-CNIO, Madrid, Spain.; Pita G; Human Genotyping Unit-CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Moya FJ; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Moreno C; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Martin MC; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Alonso R; Human Genotyping Unit-CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Nuñez-Torres R; Human Genotyping Unit-CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Sanchez-Arevalo Lobo VJ; Grupo de Oncología Molecular, Instituto de Investigaciones Biosanitarias, Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria (UFV), Madrid, Spain.; Grupo de Oncología Cutánea. Servicio de Anatomía Patológica, Hospital Universitario 12 de Octubre. Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Alonso-Guirado L; Genetic and Molecular Epidemiology group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), and CIBERONC, Madrid, Spain.; Malats N; Genetic and Molecular Epidemiology group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), and CIBERONC, Madrid, Spain.; Gonzalez-Neira A; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Human Genotyping Unit-CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.; Fernandez L; Pediatric Onco-Hematology Clinical Reseacrh Unit IdiPAZ-CNIO, Madrid, Spain.; Roda-Navarro P; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, 12 de Octubre Health Research Institute (imas12), Madrid, Spain.; Torres-Ruiz R; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. rtorresr@cnio.es.; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (Ciemat), Madrid, Spain. rtorresr@cnio.es.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain. rtorresr@cnio.es.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain. rtorresr@cnio.es.; Rodriguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. srodriguezp@cnio.es.
Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Academic Journal
Mol Biol Evol
E-Prints Complutense. Archivo Institucional de la UCM
instname
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
Docta Complutense
Academic Journal
Triviño JC; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Ceba A; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Rubio-Solsona E; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Serra D; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Sanchez-Guiu I; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Ribas G; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Rosa R; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Cabo M; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Bernad L; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Pita G; Spanish National Genotyping Center (CEGEN), Madrid, Spain.; Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; Gonzalez-Neira A; Spanish National Genotyping Center (CEGEN), Madrid, Spain.; Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; Legarda G; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Diaz JL; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; García-Vigara A; Obstetrics and Gynecology Service, Hospital Clínico Universitario - INCLIVA, Av Blasco Ibáñez 17, 46010, Valencia, Spain.; Martínez-Aspas A; Obstetrics and Gynecology Service, Hospital Clínico Universitario - INCLIVA, Av Blasco Ibáñez 17, 46010, Valencia, Spain.; Escrig M; Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Bermejo B; Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Biomedical Research Centre Network in Cancer (CIBERONC), Madrid, Spain.; Eroles P; Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Biomedical Research Centre Network in Cancer (CIBERONC), Madrid, Spain.; Ibáñez J; General Directorate Public Health, Valencian Community, Valencia, Spain.; Valencia Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain.; Salas D; General Directorate Public Health, Valencian Community, Valencia, Spain.; Valencia Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Valencia, Spain.; Julve A; Radiology Service, Hospital Clínico Universitario - INCLIVA, Av Blasco Ibáñez 17, 46010, Valencia, Spain.; Cano A; Obstetrics and Gynecology Service, Hospital Clínico Universitario - INCLIVA, Av Blasco Ibáñez 17, 46010, Valencia, Spain.; Lluch A; Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.; Biomedical Research Centre Network in Cancer (CIBERONC), Madrid, Spain.; Miñambres R; Sistemas Genómicos, Ronda Guillermo Marconi 6, Parque Tecnológico, 46980, Paterna, Valencia, Spain.; Benitez J; Spanish National Genotyping Center (CEGEN), Madrid, Spain. jbenitez@cnio.es.; Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, 28029, Madrid, Spain. jbenitez@cnio.es.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
Ghoussaini, MEdwards, SLMichailidou, KNord, SCowper-Sal Lari, RDesai, KKar, SHillman, KMKaufmann, SGlubb, DMBeesley, JDennis, JBolla, MKWang, QDicks, EGuo, QSchmidt, MKShah, MLuben, RBrown, JCzene, KDarabi, HEriksson, MKlevebring, DBojesen, SENordestgaard, BGNielsen, SFFlyger, HLambrechts, DThienpont, BNeven, PWildiers, HBroeks, AVan't Veer, LJRutgers, EJTCouch, FJOlson, JEHallberg, EVachon, CChang-Claude, JRudolph, ASeibold, PFlesch-Janys, DPeto, JDos-Santos-Silva, IGibson, LNevanlinna, HMuranen, TAAittomäki, KBlomqvist, CHall, PLi, JLiu, JHumphreys, KKang, DChoi, J-YPark, SKNoh, D-YMatsuo, KIto, HIwata, HYatabe, YGuénel, PTruong, TMenegaux, FSanchez, MBurwinkel, BMarme, FSchneeweiss, ASohn, CWu, AHTseng, C-CVan Den Berg, DStram, DOBenitez, JPilar Zamora, MPerez, JIAMenéndez, PShu, X-OLu, WGao, Y-TCai, QCox, ACross, SSReed, MWRAndrulis, ILKnight, JAGlendon, GTchatchou, SSawyer, EJTomlinson, IKerin, MJMiller, NHaiman, CAHenderson, BESchumacher, FLe Marchand, LLindblom, AMargolin, STeo, SHYip, CHLee, DSCWong, TYHooning, MJMartens, JWMCollée, JMvan Deurzen, CHMHopper, JLSouthey, MCTsimiklis, HKapuscinski, MKShen, C-YWu, P-EYu, J-CChen, S-TAlnæs, GGBorresen-Dale, A-LGiles, GGMilne, RLMcLean, CMuir, KLophatananon, AStewart-Brown, SSiriwanarangsan, PHartman, MMiao, HBuhari, SABSTeo, YYFasching, PAHaeberle, LEkici, ABBeckmann, MWBrenner, HDieffenbach, AKArndt, VStegmaier, CSwerdlow, AAshworth, AOrr, NSchoemaker, MJGarcía-Closas, MFigueroa, JChanock, SJLissowska, JSimard, JGoldberg, MSLabrèche, FDumont, MWinqvist, RPylkäs, KJukkola-Vuorinen, ABrauch, HBrüning, TKoto, Y-DRadice, PPeterlongo, PBonanni, BVolorio, SDörk, TBogdanova, NVHelbig, SMannermaa, AKataja, VKosma, V-MHartikainen, JMDevilee, PTollenaar, RAEMSeynaeve, CVan Asperen, CJJakubowska, ALubinski, JJaworska-Bieniek, KDurda, KSlager, SToland, AEAmbrosone, CBYannoukakos, DSangrajrang, SGaborieau, VBrennan, PMcKay, JHamann, UTorres, DZheng, WLong, JAnton-Culver, HNeuhausen, SLLuccarini, CBaynes, CAhmed, SMaranian, MHealey, CSGonzález-Neira, APita, GRosario Alonso, MÁlvarez, NHerrero, DTessier, DCVincent, DBacot, Fde Santiago, ICarroll, JCaldas, CBrown, MALupien, MKristensen, VNPharoah, PDPChenevix-Trench, GFrench, JDEaston, DFDunning, AM
Nat Commun
Nature Communications, vol 9, iss 1
Academic Journal
Benito-Sánchez B; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Barroso A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Fernández V; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Mercadillo F; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Núñez-Torres R; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Pita G; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Pombo L; Medical Oncology Section, Universitary Hospital Complex of Albacete, Albacete, Spain.; Morales-Chamorro R; Medical Oncology Section, Hospitalary Compex La Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain.; Cano-Cano JM; Medical Oncology Service, Universitary General Hospital of Ciudad Real, Ciudad Real, Spain.; Urioste M; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; González-Neira A; Human Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain.; Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029, Madrid, Spain. aosorio@cnio.es.; Spanish Network On Rare Diseases (CIBERER), 28029, Madrid, Spain. aosorio@cnio.es.; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, 29029, Madrid, Spain. aosorio@cnio.es.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] PITA, G
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어